# SODIUM CHLORIDE 23.4%
> **ANDA212070** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2021-04-28
## Drug
- **FDA Application Number:** ANDA212070
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM CHLORIDE 23.4%
- **Generic name:** SODIUM CHLORIDE
- **Active ingredients:** SODIUM CHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2021-04-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212070)
---
*MORVS · CC0 1.0*